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ABSTRACT 
 
The study is aimed to identify clinical signs exhibited by rats upon single 
exposure of Gamat-DEET Mosquito Repellent Rubbing Oil (GD MRRO) containing 
15% of N, N Diethyl-m-toluamide as the active ingredient with bioactivity (repellent) 
against mosquitoes which includes Gamat Rubbing Oil (GRO) the placebo item. The 
study is performed to determine the hazard category of acute dermal toxicity of the GD 
MRRO subsequently to classify it based on the WHO Pesticide Hazard Class and the 
UN-GHS harmonized classification of hazardous chemical substances. The study data 
provides a part of the safety data required for registration purpose of the test item, where 
exposure by the dermal route is definite because the test item is intended for human 
topical application on skin. The study employs method as described in the OECD Test 
Guideline 402. Results showed that all test animals dosed either with the GD MRRO or 
the GRO, survived until day-14 without mortality, moribund, severe pain or severe 
distress. There was no persistent or non-reversible clinical signs observed between day-1 
until day-14.The study concludes that the GD MRRO satisfy the hazard toxicity class of 
Category U based on WHO Recommended Classification of Pesticides by Hazard 
(WHO, 2010) and the Class 5 of Acute Toxicity Hazard Categories under the United 
Nations Globally Harmonized System for Classification of Chemical Substances and 
Mixtures (UN-GHS).Therefore, the GD MRRO and the GRO are unlikely to present 
acute hazard upon dermal contact under normal use. 
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ABSTRAK 
 
Kajian ini bertujuan untuk mengenal pasti tanda-tanda klinikal dipamerkan oleh 
tikus apabila terdedah kepada Minyak Sapu Penghalau Serangga Gamat dan DEET (GD 
MRRO) yang mengandungi 15% daripada N, N diethyl-m-diethyl sebagai bahan aktif 
dengan bioaktiviti (penghalau) terhadap nyamuk yang termasuk Minyak sapu Gamat 
(GRO) item plasebo. Kajian ini dilakukan untuk menentukan kategori bahaya ketoksikan 
kulit akut yang GD MRRO seterusnya untuk mengklasifikasikan ia berdasarkan kepada 
WHO Kelas Racun Bahaya dan UNGHS. Data kajian menyediakan sebahagian daripada 
data keselamatan yang diperlukan untuk tujuan pendaftaran produk di mana melalui 
laluan pendedahan kulit adalah pasti kerana item ujian adalah bertujuan untuk aplikasi 
topikal pada kulit manusia. Kajian ini menggunakan kaedah seperti yang dinyatakan 
dalam Garis Panduan Ujian OECD 402. Keputusan menunjukkan bahawa semua haiwan 
yang didedahkan sama ada dengan MRRO DEET atau GRO sehingga hari-14 terselamat 
tanpa kematian, hampir menemui ajal, sakit teruk atau kesusahan yang teruk. Tiada 
tanda-tanda klinikal yang berterusan atau tidak boleh diterbalikkan, diperhatikan di 
antara hari-1 sehingga kajian hari-14. Kesimpulannya, GD MRRO memenuhi kelas 
ketoksikan bahaya Kategori U berdasarkan WHO lawatan Pengkelasan Racun oleh 
Bahaya (WHO, 2010) dan Kelas 5 Kategori Ketoksikan Akut Bahaya di bawah UN-
GHS .Therefore, yang GD MRRO dan GRO tidak mungkin untuk membentangkan 
bahaya akut apabila bersentuhan kulit di bawah penggunaan biasa 
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CHAPTER 1 
INTRODUCTION 
 
Mosquito borne diseases are disease affected by mosquitos which are responsible 
in transmitting diseases such as Yellow fever, dengue fever, malaria, Japanese 
Encephalitis and filariasis. Dengue fever is the most common life threatening viral 
infection causing millions of death every year with no proper vaccine or treatment 
(Sritabutra & Soonwera, 2013) 
In Malaysia, there are 46681 cases has been reported on the incidence of dengue 
in 2014. This means that there is an increase of 246% cases compared to the year before 
(The Star Online, 2014). The figure indicated that this kind of mosquito borne disease is 
currently representing a greater health problem not only in Malaysia but several parts of 
the world. In order to avoid mosquitoes from biting the human, protection against them 
should be taken care of such as wearing protective clothing and application of repellent 
to the skin as the common approach.(Peter & Mwangi, 2014). 
There are two types of commercial insect repellents which are synthetic 
chemicals and plant derived essential oils (Fradin and Day, 2002). A synthetic mosquito 
repellent which is widely used all over the world for past 60 years is N,N-diethyl-m-
toluamide (Isman & Grieneisen, 2014). N,N-diethyl-meta-toluamide (DEET) is a wide-
spectrum and most effective synthetic repellent available in the market due to its longer 
protection time and inexpensive. In terms of health concern, insect repellent which 
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contains DEET does not poses a health concern and is safe for the uses includes children 
(EPA, 2015). Commercial DEET formulations are available in several forms such as 
pressurized aerosol, aerosol pump spray, lotions and creams, liquids, roll-ons, and 
towellettes. (Costanza et al., 2007).  
In Malay communities, sea cucumber is regarded as one of traditional ointment 
product use in medicine industry and the locals named it as “Minyak Gamat” (Woo et 
al., 2013). Gamat is actually one species of sea cucumber which is well known for its 
wound healing activity (Choo, 2004). In the present study, the finished product Gamat-
DEET Mosquito Repellent Rubbing Oil (GD MRRO) is tested on acute dermal toxicity 
of Sprague Dawley rats in order to determine the hazard category of this product. 
Gamat-DEET Mosquito Repellent Rubbing Oil (GD MRRO) is regarded as 
insecticide product. In view of GD MRRO that via topical application may cause direct 
exposure to human, the Malaysia Pesticide Board has mandated for any pesticide 
products to be evaluated for toxicological studies and provide safety data (PESTICIDE 
ACT, 1974) 
In Malaysia Pesticide Board regulations also stated that, any manufactured 
pesticide substances to be registered for sale or distribution in Malaysia shall furnish 
non-clinical safety data. (PESTICIDE ACT, 1974). Among the requirements in terms of 
toxicological data needed to register the product is acute dermal studies in rats. This is 
accordance to WHO Recommended Classification of Pesticides by Hazard Categories 
under the United Nation Globally Harmonized System for Classification of Chemical 
Substance and Mixtures (UN-GHS)  
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Table 1.1 Hazard class of an insecticide product is based on WHO Recommended 
Classification of Pesticides by Hazard (WHO, 2010) that has been aligned with the 
Acute Toxicity Hazard Categories under the United Nations Globally Harmonised 
System for Classification of Chemical Substances and Mixtures (UN-GHS) 
WHO Pesticide Hazard Class LD50 for the rat (mg/kg body weight) 
  Oral  Dermal 
Ia  
Ib  
II  
III  
U  
Extremely hazardous 
Highly hazardous  
Moderately hazardous 
Slightly hazardous  
Unlikely to present acute hazard 
< 5  
5 – 50  
50 – 200  
> 2000 
≥ 5000 
< 50 
50 – 200 
200 – 2000 
> 2000 
≥ 5000 
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In view of this, this study is done to better evaluate of the oil formulation with 
DEET and without DEET which offer high repellency as well as good consumer safety. 
Thus, this study aims to determine the hazard category of Gamat-DEET Mosquito 
Repellent Rubbing Oil based on the UN-GHS classification with three main objectives 
which are; 
1. To identify clinical signs exhibited by the rats upon single dosing of the 
test item (Gamat-DEET Mosquito Repellent Rubbing Oil) and the 
placebo (Gamat Rubbing Oil), subsequently determining the need for 
repeated dose toxicity study based on the outcome of necropsy gross 
examination. 
2. To determine the hazard category of the test item (Gamat-DEET 
Mosquito Repellent Rubbing Oil) based on the UN-GHS classification, 
subsequently concluding the suitability for sale under the group of 
household insecticide product which only accepts products with Hazard 
Class 4 and above. 
3. To determine the hazard category of the placebo item (Gamat Rubbing 
Oil) to elucidate the possible toxicity contributed by the inert ingredients. 
In conclusion, this study is important in determining the hazard class category of 
the product in order to safeguard the consumer in terms of its health hazard that the 
product may produce. It is also will help local business entrepreneur to market their 
product in European Country in the future. 
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CHAPTER 2 
LITERATURE REVIEW 
2.1 United Nation of Globally Harmonized System (UN-GHS) 
As a worldwide practice, chemicals substance are used to enhance and 
improve life especially in consumers‟ products. However, these chemical substances 
have the potential to produce adverse effect (UNECE, 2011). In most countries, the 
transmission of information about the hazard of chemical substances are developed 
through labels and/or safety data sheets. Nonetheless, due to inconsistencies in 
countries regarding classification and labeling of a same chemical substances, it may 
give a strong impact on both the protection to human health and environment 
(Winder et al., 2005). Thus, a proper classification and labelling regarding the use of 
the chemicals substance may draw attention of the user about the hazards and protect 
them from the hazards of these chemicals. Since there are diverse systems of 
classification and labelling of chemical substance around the world, there is a need 
for an internationally harmonized approach to be regulated in order to standardize the 
systems (UNECE, 2011). 
The presence of multiple existing laws or regulations on chemical 
classification and labelling such as United Nation (UN) Dangerous Goods System, 
European Community (EC) for system for hazardous substances (Winder et al., 
2005) and in Malaysia, CPL Regulation 1997 (OSHA, 1994) have variations in 
definitions of hazards and caused confusion at user level.  
As a result, at the Rio Summit in 1992, Agenda 21 has developed the concept 
of Globally Harmonized System (GHS) where it recommended the implementation 
6 
 
of GHS for classification and labelling of chemical substances. In 2003, United 
Nations (UN) collaborated with Organization for Economic Cooperation and 
Development (OECD) introduced „Globally Harmonized System of Classification 
and Labelling of Chemicals‟ (GHS) (UNECE, 2003) with the most current revision 
published in 2011 (UNECE, 2011). Thus, UN-GHS chemical classification is 
purposely developed to standardize worldwide safe chemical management issues 
from manufacturer, transport, usage and disposal (Winder et al., 2005). 
2.1.1 Hazard Classification 
 
As for the term of hazard classification, it includes the compilation of all 
relevant data need to be carried out by the supplier to place the chemical substance or 
products on the European Union market. In order to determine the hazard class, a cut 
off values for maximum levels is to be considered when evaluating test result of 
animal experiments. These cut-off values shall reflect a threshold between 
toxicological relevance and non-relevance to humans covering all exposure situations 
presumably appearing under real-life conditions. Thus, a proper classification and 
labelling is required to identify and specify the hazard class of the chemical 
substance or the product (Gebel et al., 2009). 
As an internationally agreed system for classification and labelling of 
chemical substances or mixtures, GHS classified them in terms of physical hazard, 
health (toxicology) hazard and environmental hazard which covers range of 
consumer products, workplace, pesticides and transportation. Implementation of 
GHS not only protect human health and environment but indirectly promote 
chemical trade between countries all over the world (Thannimalay & Yusoff, 2008). 
Below are the three categories  
7 
 
a) Physical Hazard : Chemical substances in this category will be classified 
not only for hazard type (hazard class, e.g flammability) but also the degree 
of hazard presented (hazard category e.g extremely flammable, highly 
flammable). 
b) Toxicology (or Health) Hazard : In this category, a chemical substance is 
concerned about its potential to posed health effects to human. 
c) Ecotoxicological (or Environmental) Hazard : In environmental hazard, it 
classified chemical substances which are  hazardous for the aquatic 
environment.            (Winder et al., 2005) 
The communication of hazard in the GHS is based on the provision of signal 
words, hazard statements and pictograms, all of which are linked to the specific 
hazard of the substance or mixture (Silk, 2003).  
In European market, chemical substances are regulated by the European 
Union Regulation on chemicals and their safe use commonly known as Registration, 
Evaluation, Authorisation and Restriction of Chemicals (REACH) in 2007 (Gebel et 
al., 2009). REACH represents a major piece of chemical legislation in Europe which 
aims to ensure a high level of protection of humans and the environment by 
classifying them according to their physicochemical, environmental or human health 
hazards (Oltmanns et al., 2014). 
2.1.2 Health Hazard 
 
The term health hazard can be defined as chemical substance which may 
result in acute or chronic health effects to a person based on at least one study 
conducted with established scientific principles. The health hazard that may occur 
would be in terms of carcinogens, toxic or highly toxic agents, reproductive, irritants, 
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corrosives, sensitizers, hepatotoxins, nephrotoxins, neurotoxins and agent which may 
cause damage to heamatopoietic system and respiratory system (ILIP, 2015). 
In health hazard classification, it covers criteria in terms of acute toxicity, 
skin and eye irritation/corrosion, danger of irreversible effects after single exposure 
and danger of serious damage to health by prolonged exposure (Gebel et al., 2009). 
Below is a summary of all criteria have been developed for the classification of the 
following types of health effects according to GHS classification system :  
a) Single dose toxicity, covering a range of toxicity endpoints by various 
routes of exposures (Table 2.1). 
b) Skin irritation and corrosion. As for Category 1 is for corrosive effects and 
Categories 2 and 3 for irritation (Table 2.2). 
c) Eye irritation and serious eye damage. As for Category 1 is for corrosive 
effects and Categories 2A and 2B for irritation (Table 2.2) 
d) Skin or respiratory sensitisation. As for serious effect of sensitization, new 
label is shown in Table 2.4.  
e) Single or repeated dose target organ systemic toxicity (TOST). This uses 
similar criteria for both single and repeated exposures (Table 2.4). 
f) Genotoxicity and germ cell toxicity as shown in Table 2.5. 
g) Reproductive toxicity as well as developmental toxicity in the offspring 
(Table 2.5). 
f) Carcinogenicity criteria with two broad categories (Table 2.6).  
                                (Winder et al., 2005)
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Table 2.1 GHS Criteria, single dose toxicity 
         (Winder et al., 2005) 
 
 
 
 
 Toxicity Category 
1 2 3 4 5 
 
   
 
Oral (mg/kg) 5 50 300 2000 Oral LD50 between 
2000 and 5000 mg/kg  
Indication of 
significant effect in 
humans 
Any mortality in 
Category 4 
Indication from other 
studies 
Dermal (mg/kg) 50 200 1000 2000 
Gases (ppm) 100 500 2500 5000 
Vapour (mg/L) 0.5 2 10 20 
Dust and mists 
(mg/L) 
0.05 0.5 1 5 
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Table 2.2 GHS criteria, skin corrosion/irritation and serious eye damage/eye irritation 
 
Destruction of skin tissue; visible necrosis in 
one or more of three animals 
Reversible adverse effects in skin tissue 
Category 1 
 
 
Category 2 Category 3 
 
 
Subcategory 
1A 
Subcategory 
1B 
Subcategory 
1C 
 
Exposure: 3 
min or less 
Observation: 
Up to 60 min 
Exposure: 3 
min and 1h 
Observation: 
Up to 14 days 
Exposure: 
between 1 
and 4h 
Observation : 
Up to 14 days 
Exposure: 3 
min or 
Mean irritation score of 1.5–
2.3 for erythema/eschar or for 
oedema in at least two of 
three tested animals at 24, 48 
and 72h 
 
Category 1 Category 2 
 
 
Adverse effects on conjunctiva, cornea, iris 
that have not reversed within the observation 
period (normally 21 days after exposure) in at 
least one animal, and/or 
In at least two of three tested animals, a 
positive response of corneal opacity with a 
mean score of 3 or above, and/or a mean score 
of more than 1.5 for iritis, at 24, 48 and 72 h 
Reversible adverse effects on conjunctiva, 
cornea, iris 
Mean irritation score in at least two of three 
tested animals of 1 or more for corneal opacity 
and or 1 or more for iritis, and/or mean scores 
of 2 or more for redness and/or 2 or more for 
conjunctival oedema (chemosis) 
 Subcategory 2A 
 
 
 
 
Subcategory 2B 
 Reversible in 21 days Reversible in 7 
days 
 
(Winder et al., 2005) 
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Table 2.3 GHS criteria, respiratory or skin sensitization and single or repeated target 
organ systemic toxicity (TOST) 
Respiratory 
sensitization 
Category 1 
 
 
 
 
 
 
 
 
 
Evidence in humans of specific respiratory sensitivity and/or  
Results of respiratory sensitivity from animal studies 
 
Skin sensitization Category 1 
 
  
 
 
 
 
Evidence in humans of sensitisation by skin contact in a substantial 
number of persons, or Results of skin sensitivity from appropriate 
animal studies 
 
 
 
(Winder et al., 2005) 
 
 
Category 1 Category 2 
 
 
 
 
 
Significant toxicity in humans 
 
Presumed to be harmful to human health 
Significant toxicity in humans Reliable, good 
quality human case studies or epidemiological 
studies 
Presumed significant toxicity in humans 
Animal studies with significant and/or severe 
toxic effects relevant to humans at a generally 
(as a guide) low exposures 
Animal studies with significant toxic effects 
relevant to humans at generally moderate (as a 
guide) exposure 
Human evidence in exceptional cases 
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Table 2.4 GHS criteria, germ cell mutagenicity and reproductive and developmental 
effects 
Category 1 
 
 
 
 
 
 
 
Category 2 
 
Subcategory 1A Subcategory 1A May induce heritable mutations 
in human germ cells 
Known to produce 
heritable mutations in 
human germ cells 
 
Positive evidence from 
human epidemiological 
studies 
Should be regarded as if they 
produce heritable mutations in 
the germ cells of humans  
 
Positive results in: 
Human germ cell tests In vivo 
heritable germ cell tests in 
mammals In vivo somatic 
mutagenicity tests, combined 
with some evidence of germ cell 
mutagenicity 
Positive evidence from tests in 
mammals and somatic cell tests 
In vivo somatic genotoxicity 
supported by in vitro 
mutagenicity 
 
(Winder et al., 2005) 
Category 1 
 
 
 
 
 
 
Known or presumed to cause effects on human 
reproductive ability/capacity or on 
development 
 
Category 2 
 
 
 
 
 
 
Suspected to cause effects on human 
reproductive ability/capacity or on 
development 
 
Subcategory 1A Subcategory 1B  Additional 
category effects 
on lactation Or 
effects via 
lactation 
Known (based on 
human data) 
Presumed 
Presumed (based on 
animal data) 
Suspected 
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Table 2.5 GHS criteria, carcinogenicity 
Category 1 Category 2  
 
 
 
 
Known or presumed  
human carcinogen 
 
 
 
 
 
Suspected human carcinogen 
 
Subcategory 1A Subcategory 1B 
Known human carcinogen 
based on human evidence 
Presumed human carcinogen 
based on demonstrated 
animal carcinogenicity 
Suspected 
Limited evidence of human or 
animal carcinogenicity 
 
(Winder et al., 2005) 
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2.1.3 Acute Toxicity 
 
In marketing chemicals for international distribution, the estimation of 
mammalian acute systemic toxicity is important. Concerning on the regulatory respond 
for hazard classification and labelling by industrial chemicals, agrochemicals, biocides 
and pharmaceuticals, acute toxicity is conducted. (Seidle et al., 2010). Thus, GHS has 
implemented rules for classification of human acute toxicity categories based on 
experimental findings (UN, 2011). The findings are obtained from oral, dermal or 
inhalation of single dose exposure of rodents and calculation lethality based on 
concentration effect (Seidle et al., 2010).  
There are five acute toxicity categories to determine certain threshold for LD50 
namely : category I to III is labelled as „danger‟, category IV is labelled as „warning‟ and 
category V has no label. As for category V, compounds are comprised of low acute 
systemic toxicity. Different categories has certain threshold which are specific for the 
exposure route (i.e oral, dermal, or inhalation). The „warning‟ label is to classify the 
most severe hazard category (UN, 2011). 
According to GHS, acute toxicity is defined as “those adverse effects occurring 
following oral or dermal administration of a single dose of a substance, or multiple doses 
given within 24 hours, or an inhalation exposure of 4 hours”. In another word, acute 
toxicity is the potential of a substance to produce human hazard by determining its 
systemic toxicity in a test system based on the median lethal dose (LD50) value which 
means 50% of the test animal will kill upon exposure of a single dose of test substance 
(UNECE, 2004). 
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Acute toxicity testing also is called as acute systemic toxicity. In order to have 
systemic toxic effects, a toxic substance must be absorbed by the body. Then, the toxic 
substance is distributed by the circulation and exerts its toxic effects to the target cell or 
organ. The observed toxicity is a result of liver biotransformation to convert a drug or 
chemical to a new form or metabolites. There are five (OECD) Test Guidelines (TG) 
which describes acute systemic testing namely TG 402, TG 403, TG 420, TG423, and 
TG 425. As for the testing guidelines, World Health Organization (WHO) through GHS 
(UN, 2011) has recommended testing procedures by referring to Organization for 
Economic Cooperation and Development (OECD) testing guidelines (Scholz et al., 
2013).  
 Being considered as the leading international standard for safety testing and the 
development of new Test Guidelines (TG), the OECD Test Guidelines plays a vital role 
on testing and assessment. Due to this respect, OECD‟s Environment, Health and Safety 
(EHS) has established the development of harmonized test method as the basis of any 
risk assessment procedure (Barlow et al., 2002). 
As for new chemical substances of products, the active compound and final 
commercial products are required to be proven safe before entering European market. 
(Scholz et al., 2013). Thus, any data developed in one country accordance to Good 
Laboratory Principle (GLP) and OECD Test Guidelines, they are accepted for 
assessment purposes in all OECD countries. As a result, it may save a lot by avoiding 
duplicative testing and minimizing non-tariff barriers in trading products (Koe, 2003). 
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2.2 Acute Dermal Toxicity Study  
Acute dermal toxicity is defined as application of a test substance to no less than 
10% of rats, rabbits, or guinea pigs skin followed by 14 days of observation. LD50 is 
determined by the number of animals‟ death and gross pathological changes are to 
ascertain the relative toxicity of a substance. Acute dermal toxicity study is referred as 
OECD Test Guidelines 402 (OECD, 1987). 
Determination of acute dermal toxicity is important in evaluating and assessing 
the toxic characteristic of a substance when the route of exposure is by dermal route. As  
a short term exposure, acute dermal toxicity gives information on health hazards likely 
to arise. In fact, the data collected from acute dermal toxicity provides a basis for 
classification and labelling. In addition, the data also needed in determining the dose for 
subchronic and other studies on dermal absorption (OECD, 1987). 
2.2.1 Skin anatomy and physiology 
 
Skin is regarded as the largest organ in human body weighing about 5 kg with a 
surface area of 2 m2 (Godin & Touitou, 2007). Skin functions as protection from 
surrounding environment by forming an efficient permeation barrier for exogenous 
molecules. This multi-layered organ acts mainly to protect the body from the 
surrounding environment, thus forming an efficient permeation barrier. There are two 
main layers of skin namely epidermis and dermis as shown in Figure 2.1. 
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Figure 2.1 Skin structure and its function (Venus et al., 2011)
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In between the epidermis and dermal layer there is a basement membrane 
comprises of a thin layer of specialized extracellular matrix. As for the dermal layer 
which located under the basement layer, it consists of two regions which are papillary 
dermis and reticular dermis. In the papillary regions of the dermis it is composed of thin 
collagen fibers whereas the reticular dermis is composed of thicker, denser collagen 
fibers (Mikesh et al., 2013). 
Epidermis represents the outer layer of organism which acts as a protection 
barrier to penetration of chemicals to the underlying vascular dermis (Venus et al., 
2011). It comprises of four compartments namely stratum basale, stratum spinosum, 
stratum granulosum and stratum corneum (Breitkreutz et al, 2013). Below are the 
description of each stratum :  
 Stratum basale (basal cell layer) 
In this layer, it is only one cell thick and the main cell is keratinocyte. The 
melanocyte is also present and comprises of 5-10% of the cell population. 
 Stratum spinosum (spinous or prickle cell layer) 
As the basal cells move towards the surface it form a layer of polyhedral cells 
connected by desmosomes and seen as „prickles‟ under the microscope. 
Langerhans cells are present in this layer. 
 Stratum granulosum (Granular cell layer) 
In this layer, keratinocytes are found in the granular layer which contains 
intracellular granules of keratohyalin. The lipid contents is discharged from to 
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cells into the intercellular space plays a vital role for the barrier function and 
intercellular cohesion within the stratum corneum. 
 Stratum corneum (horny layer) 
The outermost layer of the epidermis is stratum corneum in which the cells 
migrated from stratum granulosum. The cells in this layer are called as 
corneocytes with nuclei and cytoplasmic organelles have been lost (Venus et al., 
2011). 
2.2.2 Mechanism of Skin Absorption  
 
In order to determine the amount of a chemical penetrate into the skin, dermal 
penetration study is done. It is done to determine the potential of the substance to be 
absorbed into systemic circulation (OECD, 2004a). However, before systemic 
absorption occurs, biotransformation of the test substance within the skin can take place 
before dermal penetration by passive diffusion.  
In latest study shows that biotransformation of human skin occur due to the fact 
that it possess multiple cytochrome P450 isoenzymes, influx and efflux transporter 
proteins. Although the patterns of cytochrome P450 isoenzymes differ from liver, it 
seems that skin can involve in both Phase I and Phase II metabolic reactions. There are 
at least five different esterases reported to work upon simple ester bonds such as in 
organophosphate compounds. Therefore, the ultimate fate and bioavailability of a 
chemical may be influenced by dermal biotransformation (Abdallah et al., 2015)  
Skin absorption may occur depending on a few factors that affect the permeation 
of a substance through the skin. This includes contact area, duration of exposure, 
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lipophilicity, test substance concentration, molecular weight, epidermis thickness and 
the integrity of stratum corneum (OECD, 2004b). The rate if dermal penetration depends 
on the qualities of stratum corneum as it acts as excellent barrier property by protecting 
the skin against penetration.  
In dermal absorption studies, human skin is preferably chosen for in vitro study 
whereas for in vivo studies, rat skin is used to see the effect in human exposure. Rat skin 
represent for a worst case model for human skin. Even though rat skin is anatomically 
different in terms of thinner stratum corneum and more hair follicles as to compare to 
human skin, it is more permeable to chemicals (Aggarwal et al., 2015). Although the 
effect of dermal absorption is slower, prolonged exposure may cause severe toxicity. 
Thus, to enhance dermal absorption, lipophilic agent can be used and helped by the 
solvent and emulsifier used in the formulation (Naggar et al., 2009). 
Stratum corneum (SC) provides the barrier properties of the skin and contains up 
to 16 cell layers and it takes up two weeks to completely desquamate (Hoath & Leahy, 
2006). SC has highly hydrophobic layer which composed of differentiated non-nucleated 
cells, corneocytes filled with keratins, and embedded in the lipid domain. Molecules 
penetrate through SC via passive diffusion or via sweat glands and hair follicles directed 
towards dermis layer. The function of influx transport proteins in human skin in in 
dermal uptake of xenobiotics is unknown. However, the role of organic anion 
transporting polypeptides (OATP) is highlighted in terms of mediating large organic 
cations via human keratinocytes by active transportation.(Schi et al., 2003) 
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Other than the role played by stratum corneum as epidermal barrier, other 
molecules such as xenobiotic metabolizing enzymes and transport protein act as second 
biochemical barrier of the skin. Thus, chemical residues will be limited to the epidermis 
layer and eliminated from the exposed skin by desquamation so that it is not available 
for systemic distribution (Aggarwal et al., 2015). 
However, there are four mechanism has been found to overcome to this problem. 
Since stratum corneum has a tightly packed lipid region, skin resistance can be reduced 
by disrupting the permeability of lipid region which result in increasing penetration 
through the intercellular lipid matrix. Other possible mechanism is by increasing the 
drug partitioning into the stratum corneum through formation of ion pair between the 
drug and fatty acid. Another mechanism is by increasing the drug solubility into the skin 
by having the drug to have high affinity for the solvent. Lastly is by increasing drug 
solubility in the vehicle such as acidic enhancers to increase the solubility of basic drugs 
(Gwak & Chun, 2002) 
2.2.3 Toxicity effect upon skin exposure 
 
Acute dermal toxicity testing is designed to assess the local and/or systemic 
effects of a chemical after exposed to the dermal route. It only indicates either the 
penetration of a substance may produce a systemic toxicity not the amount of chemical 
absorbed. The evaluation of systemic toxicity effects is due to percutaneous absorption 
of the test material whereas the local toxicity is determined by its contact with the skin. 
The absorption of the test material can be determined from observation of these effects 
either the material is sufficient to produce systemic effects or lethality (Arteaga et al., 
2014). 
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Local effects due to dermal exposure can be described into a few criteria such as, 
oedema, eschar formation, acanthosis, necrosis hyperkeratosis and papillomas. All the 
criteria may contribute significantly to morbidity (Schaafsma et al.,, 2011). Skin 
erythema can be defined as an inflammatory disorder that produces tender red bump 
(nodules) under the skin. The factor that might cause erythema is due to sensitivity of a 
drug. Edema is an allergic reaction caused by sensitivity of certain irritants or chemical 
substances. Edema is reversible as it may return to normal once the cause is identified 
and eliminated whereas eschar is termed as dead tissue cell due to skin injury (Arteaga et 
al., 2014) 
In order to assess systemic toxicity of a chemical exposure, two factors are 
responsible for it which are penetration through the skin and the toxic potency. As skin 
is a good water barrier, skin penetration is different between substance as it is depending 
on lipid and water solubility of chemical through the skin. The toxicity effect cannot be 
determined by the amount of chemical on the skin surface. Thus, internal dose can be 
predicted by using experimental measurement of permeability coefficient (Kp) and 
steady-state flux. The other factor is by determining the toxic potency of a chemical by 
its mechanism of action. In measuring general toxicity, lethal dose (LD50) of half 
experimental animals, the lowest observable effect level (LOEL) and the no observable 
effect level (NOEL) are taken into account. Thus, it is possible if a nontoxic chemical 
has high rate of skin penetration compared to toxic chemical which do not penetrate skin 
at all (McDougal et al., 2007). 
In cosmetic formulation, essential oil such as in perfumes and massage oil are 
employed. By penetrating into human skin via passive diffusion, topical formulation also 
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enhance skin permeability to other bioactive ingredients. As a result, their percutaneous 
release is can be evaluated and may become highly relevant for their quality and safety 
assessment (Gabbanini et al., 2009). 
2.3 Insect Repellent 
Insect repellent can be defined as a chemical volatile substance which act locally 
at a distance by preventing an arthropod from flying to, landing on or biting human or 
animal skin (Choochote et al., 2007). An ideal repellent should have longer protection 
against biting insects and does not cause adverse effect (Lupi et al., 2013). It can be 
classified into two types which are synthetic insect repellents and plant derived essential 
oil insect repellent (Fradin & Day, 2002).  
Synthetic insect repellent such as N,N-diethyl-m-toluamide (DEET) is considered 
as a gold standard of insect repellent as it is developed and used since World War II by 
the US military. It is the most effective insect repellent which not only can be applied on 
skin, but also on fabrics. Natural insect repellent includes citronella oil, cedar oil, 
lemongrass oil and some others are listed by Environmental Protection Agency (EPA) to 
have minimum risk pesticides which enable them to be exempted from federal 
regulation. (Katz et al., 2008; Leal, 2014). 
2.3.1 Formulation 
 
There are many formulations of insect repellent available in the market. This 
includes insect repellents in chemical forms such as sprays, creams, lotions, aerosols, 
oils and grease sticks (Lupi et al., 2013). As for insecticidal products which are easily 
accessible in the market also include mosquito coils, vaporizing mats and liquid 
vaporizers (Sinha et al., 2006). As part of personal protection measures, topical 
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application of insect repellents will reduce human contact with vector and nuisance 
arthropods. Therefore, when other methods are not accessible or impractical, topical 
repellents are used as primary importance against arthropod vectors (Antwi et al., 2008). 
The efficacy of a pesticidal products is depending on the type of formulations. 
External factors such as air temperature, humidity and wind speed may influence the 
repellency efficacy in warm and humid climates. As for example, in condition of warm 
and humid climates, the duration of effectiveness is generally slower. Thus, more 
reapplications of the repellents are needed. The repellency effectiveness is decreased by 
evaporation rate and percutaneous penetration. As for example, products which 
contained are able to penetrate deeper into skin which result in loss of effectiveness 
(Lupi et al.,. 2013).  
The primary mechanism which limits the duration of efficacy due to loss of 
active ingredients are through percutaneous and evaporation, product wash off or rub 
off. Thus, to increase activity loss, ethanol was used in commercial formulation as 
primary ingredient of DEET permeation enhancer (Karr et al., 2012). 
According to the WHO Recommended Classification of Pesticides by Hazard in 
2009, it stated that any products intended for final classification of a formulation should 
be based on toxicity data obtained on that formulation by the manufacturer (WHO, 
2009). 
In formulation of final product of pesticide, active and inert ingredients are 
combined. By definition, an inert ingredient is an intentionally added substances to a 
pesticidal product. This is done to enhance the performance of the product such as 
